Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557751 · ClinicalTrials.gov registry record · NA
Acute Pain Genomic Study
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT01557751 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 156 participants.
The verdict
NCT01557751, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
In preparation for future large-scale genome wide association studies, reliable methods must be developed for measuring perceived pain and for estimating the effects of potentially confounding factors such as appropriate covariates. The major objectives of our pilot investigation are to develop optimal methods to characterize the primary endpoint of the study-knee pain, and to gather preliminary data on genetic markers in the human genome that are associated with a certain pain phenotype. The specific issues for this study will be to carry out a preliminary gene association analysis of acute perioperative pain in individuals undergoing total knee replacement and to define a pain phenotype that is composed of multidimensional domains such as opioid consumption, inflammatory markers, anxiety level, degree of catastrophizing, etc. This pain phenotype has to be sensitive enough to pick up changes in pain experience that can be attributed to single nucleotide polymorphisms.
Interventions
- GENETIC Whole blood for genotyping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01557751
The ClinicalTrials.gov registry entry for NCT01557751 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole blood for genotyping is the first listed.
NCT01557751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01557751 about?
NCT01557751 is a clinical study titled "Acute Pain Genomic Study". In preparation for future large-scale genome wide association studies, reliable methods must be developed for measuring perceived pain and for estimating the effects of potentially confounding factors such as appropriate covariates. The major objectives of our pilot investigation are to develop opti...
What is the current status of trial NCT01557751?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2010-02. Estimated completion is 2012-04-08.
What interventions are being tested in trial NCT01557751?
The interventions under investigation include: Whole blood for genotyping (GENETIC).
Who is sponsoring clinical trial NCT01557751?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.